What Insulet’s EVOLUTION 2 data means for automated insulin delivery in type 2 diabetes
Insulet’s EVOLUTION 2 study shows 68% TIR with no boluses in type 2 diabetes. Analysis of what the FCL data means before the EVOLVE pivotal trial.
Can wearable ultrasound reinvent breast imaging? What the iSono Health ATUSA launch really signals
iSono Health launches ATUSA™, the first wearable breast ultrasound. Find out how it could transform access, accuracy, and economics in breast imaging.
FDA clears VizMark’s VM1 tumor marker: Is this the fix for MRI artifact in breast imaging?
VizMark’s VM1 marker receives FDA clearance for artifact-free breast imaging. Find out how this may change tumor localization in dense breast cases.
Can Alessa’s Enolen implant change how early-stage prostate cancer is treated?
Alessa’s Enolen earns FDA fast track for localized prostate cancer. Find out how this implant could redefine early-stage treatment and challenge current norms.